Cargando…
Immunosignaturing Can Detect Products from Molecular Markers in Brain Cancer
Immunosignaturing shows promise as a general approach to diagnosis. It has been shown to detect immunological signs of infection early during the course of disease and to distinguish Alzheimer’s disease from healthy controls. Here we test whether immunosignatures correspond to clinical classificatio...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397978/ https://www.ncbi.nlm.nih.gov/pubmed/22815729 http://dx.doi.org/10.1371/journal.pone.0040201 |